blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1187615

EP1187615 - IMMUNOSURPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.07.2009
Database last updated on 31.08.2024
Most recent event   Tooltip03.07.2009Application deemed to be withdrawnpublished on 05.08.2009  [2009/32]
Applicant(s)For all designated states
4 AZA IP NV
Kapucijnenvoer 33
3000 Leuven / BE
[2007/19]
Former [2003/14]For all designated states
4 AZA Bioscience nv
Kapucijnenvoer 33
3000 Leuven / BE
Former [2002/12]For all designated states
K.U. Leuven Research & Development
Groot Begijnhof, Benedenstraat 59
3000 Leuven / BE
Inventor(s)01 / WAER, Mark, Jozef, Albert
Waversebaan 263
B-3001 Heverlee / BE
02 / HERDEWIJN, Piet, André, Maurits, Maria
Olivierstraat 21
B-3111 Rotselaar/Wezemaal / BE
03 / PFLEIDERER, Wolfgang, Eugen
Lindauerstrasse 47
D-78464 Konstanz / DE
 [2002/12]
Representative(s)Weiss, Wolfgang, et al
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Richard-Strauss-Strasse 80
81679 München / DE
[N/P]
Former [2008/15]Weiss, Wolfgang, et al
Weickmann & Weickmann Patentanwälte Kopernikusstrasse 9
81679 München / DE
Former [2003/14]Bird, Ariane, et al
Bird Goen & Co, Klein Dalenstraat 42A
3020 Winksele / BE
Former [2002/12]Prins, Hendrik Willem, et al
Arnold & Siedsma, Advocaten en Octrooigemachtigden, Sweelinckplein 1
2517 GK Den Haag / NL
Application number, filing date00902660.002.02.2000
[2002/12]
WO2000EP00938
Priority number, dateUS19990118295P02.02.1999         Original published format: US 118295 P
US19990118235P02.02.1999         Original published format: US 118235 P
US19990118282P02.02.1999         Original published format: US 118282 P
[2002/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0045800
Date:10.08.2000
Language:EN
[2000/32]
Type: A2 Application without search report 
No.:EP1187615
Date:20.03.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 10.08.2000 takes the place of the publication of the European patent application.
[2002/12]
Search report(s)International search report - published on:EP10.01.2002
ClassificationIPC:A61K31/505, A61K38/13, A61K31/52, A61K31/535, A61K31/57, C07D475/02, A61P37/06, A61P37/00, // A61K31/435, A61K31/42
[2007/24]
CPC:
A61K31/535 (EP); A61K31/505 (EP); A61K31/52 (EP);
A61K31/57 (EP); A61K38/13 (EP); A61P37/00 (EP);
A61P37/06 (EP) (-)
C-Set:
A61K31/505, A61K2300/00 (EP);
A61K31/505, A61K31/42 (EP);
A61K31/505, A61K31/435 (EP);
A61K31/52, A61K2300/00 (EP);
A61K31/52, A61K31/505 (EP);
A61K31/535, A61K2300/00 (EP);
A61K31/535, A61K31/505 (EP);
A61K31/57, A61K2300/00 (EP);
A61K31/57, A61K31/505 (EP);
A61K38/13, A61K2300/00 (EP);
A61K38/13, A61K31/505 (EP)
(-)
Former IPC [2002/12]A61K31/505, A61K38/13, A61K31/52, A61K31/535
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/12]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IMMUNODEPRESSIVE EFFEKTE VON PTERIDIN-DERIVATEN[2002/12]
English:IMMUNOSURPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES[2002/12]
French:EFFETS IMMUNOSUPPRESSEURS DES DERIVES DE PTERIDINE[2002/12]
Entry into regional phase28.08.2001National basic fee paid 
28.08.2001Designation fee(s) paid 
28.08.2001Examination fee paid 
Examination procedure29.08.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.08.2001Examination requested  [2002/12]
02.10.2008Despatch of a communication from the examining division (Time limit: M04)
13.02.2009Application deemed to be withdrawn, date of legal effect  [2009/32]
19.03.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/32]
Fees paidRenewal fee
26.02.2002Renewal fee patent year 03
16.01.2003Renewal fee patent year 04
15.01.2004Renewal fee patent year 05
17.01.2005Renewal fee patent year 06
09.01.2006Renewal fee patent year 07
11.12.2006Renewal fee patent year 08
31.01.2008Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
28.02.200910   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]WO9411001  (CELL THERAPEUTICS INC [US]) [X] 1,3,11-14 * page 3, lines 9-12; claims 1,6,12 * * page 5, line 19 - page 6, line 27 * * page 9, line 7 - page 14, line 32 * * page 17, lines 10-16 * * page 21 * * page 27, lines 12-26 * [A] 2,4,5,7;
 [X]WO9422449  (CELL THERAPEUTICS INC [US]) [X] 1,12-14 * page 1, lines 7-9; claims 11,19 * * page 4, lines 9-11 * * page 8, lines 10-27 * * page 11, lines 11-24 *;
 [X]WO9513075  (CELL THERAPEUTICS INC [US]) [X] 13 * claims 1,6 *;
 [X]WO9531469  (US GOV HEALTH & HUMAN SERV [US]) [X] 13 * page 3, lines 8-16 * * page 3, lines 8-16; claim 1 *;
 [A]WO9610568  (MERCK & CO INC [US], et al) [A] 1 * pages 30-31 ** page 117, lines 18-25 *;
 [XA]WO9620710  (UNIV CALIFORNIA [US]) [X] 1-10,13 * pages 16-19; claims 6-9,18 * * page 23, lines 4-26; claims 22,25,26,30 * [A] 12,14;
 [XA]US5641783  (KLEIN J PETER [US], et al) [X] 1,3,12-14 * column 25 * * column 4, lines 13-21 * * columns 9-14; claims 1-3,11,18 * [A] 2,4,5,7;
 [XA]WO9852948  (UNIV CALIFORNIA [US]) [X] 1-10,13 * page 3, lines 1-13; figure 10 * * page 5, lines 11-19 * * page 4, lines 12-20 * * page 7, lines 15-22 * * pages 31-34; claims 1-4,8,20-23 * [A] 11,12,14;
 [XA]  - COTTAM ET AL, "Substituted Xanthines, Pteridinediones, and Related Compounds as Potential Antiinflammatory Agents. Synthesis and Biological Evaluation of Inhibitors of Tumor Necrosis Factor-alpha", J. MED. CHEM., (1996), vol. 39, no. 1, pages 2 - 9, XP000906858 [X] 1-3,12,13 * page 2, column L; table 1 * * page 5, column R, paragraph 2 * [A] 4,5,10,14

DOI:   http://dx.doi.org/10.1021/jm940845j
 [A]  - BUU-HOI, N. P. ET AL, "Phthalonimides (1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolines) of potential biological interest", J. HETEROCYCL. CHEM., (1968), vol. 5, no. 4, pages 545 - 547, XP000906859 [A] 1,12-14 * the whole document *

DOI:   http://dx.doi.org/10.1002/jhet.5570050416
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.